
Opinion|Videos|August 2, 2024
High-Risk Populations for Severe Pneumococcal Infection
Key opinion leaders identify high-risk populations for invasive pneumococcal disease, explain the underlying factors contributing to their increased susceptibility, and offer strategies to improve suboptimal vaccination rates, particularly among historically underserved communities.
Advertisement
Episodes in this series

- Who are the high-risk
populations for developing invasive pneumococcal disease?- What is the rationale for why certain populations are at risk for severe pneumococcal infections?
- How can we improve inadequate pneumococcal vaccine uptake rates, specifically in historically marginalized groups?
Newsletter
Stay informed on drug updates, treatment guidelines, and pharmacy practice trends—subscribe to Pharmacy Times for weekly clinical insights.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Pharmacy Times
1
TrumpRx Launches, Offering Cash-Paying Patients Discounted Drugs
2
SGLT2 Inhibitors in T2D Lower 5-Year Risk of CKD and Acute Kidney Injury
3
Pharmacist Takeover: CAR T Therapy Signals a Shift in ALL Treatment
4
Balancing Survival and Quality of Life in Pancreatic Cancer: Expert Perspectives From an Immuneering Panel
5


























